The Venture Codex Logo

The Venture Codex

Overview

Biotech company developing immuno-oncology antibodies with Smart Technology

Total Raised

$155 M

Rounds

4

Links

Verticals

Biotechnology
Medical
Oncology
Therapeutics

Investment History

  1. Series D

    Jan 2020

    $69M

  2. Series C

    Mar 2018

    $50M

  3. Series B

    Jan 2016

    $28M

  4. Series A

    Dec 2014

    $8M

Team

Peter Luo

Cofounder, CEO, President

Felix Du

Vice President of Technology Development

Steven Fischkoff

Interim Chief Medical Officer

Kristine She

Vice President of Operations